Loading organizations...
§ Venture Capital · Cambridge, MA, USA
Venture capital firm investing in early-stage biotechnology and life sciences companies focused on longevity and aging science.
Based in San Francisco, California, age1 is a venture capital firm that invests in early-stage biotechnology and life sciences startups focused on longevity, aging biology, and human healthspan extension. The organization primarily leads seed and Series A funding rounds for founder-led teams developing novel therapeutics, diagnostics, and preventative technologies targeting age-related diseases. To support its specialized investment strategy, the firm launched a $160 million debut fund with an initial $55 million closing, building upon the historical performance of prior longevity-focused investment vehicles that managed $26 million in total assets. The firm allocates capital to accelerate the transition from traditional sick care to health preservation, backing a portfolio that includes notable biotechnology companies such as Loyal, Gordian Biotechnology, and Spring Discovery. age1 was officially founded in 2023 by general partners Laura Deming and Alex Colville.
Key people at age1.
age1 has 3 tracked investments across 2 companies. The latest tracked deal is $100.0M Series C in Loyal in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 11, 2026 | Loyal | $100.0M Series C | Age1 | Baillie Gifford |
| Feb 9, 2026 | Aerska | $39.0M Series A | Age1, EQT | Iaso Ventures |
| Oct 6, 2025 | Aerska | $21.0M Seed | Age1, Backed, Speedinvest | ADA Ventures, BlueYard Capital, Kerna, Lingotto, Norrsken VC, PsyMed Ventures, Seed Club Ventures |
Key people at age1.
age1 is an investment firm focused on impact investing, aiming to deploy capital in ways that generate both financial returns and positive social or environmental outcomes. Its mission centers on supporting startups and ventures that address critical challenges while fostering economic growth, particularly in underserved or overlooked regions. The firm’s investment philosophy emphasizes reducing bias in funding decisions by leveraging data-driven approaches and innovative fund structures to connect impact-driven entrepreneurs with capital. Key sectors typically include technology, life sciences, climate tech, and social impact ventures. By targeting early-stage companies and regional innovation hubs, age1 contributes to diversifying the startup ecosystem and expanding access to venture capital beyond traditional centers like Silicon Valley[1][2][3][4].
While specific founding details for age1 are not available, impact investment firms like age1 often emerge from a recognition of persistent funding gaps in underserved communities and sectors. Founders usually bring backgrounds in venture capital, social entrepreneurship, or philanthropy, motivated by the desire to combine financial success with measurable societal benefits. Early traction for such firms often involves launching innovative fund models that prioritize transparency, peer selection, or regional focus to overcome traditional investor biases and mobilize capital more equitably[1][3][4].
age1 rides the growing trend of impact investing, where capital is increasingly allocated to ventures that deliver measurable social and environmental benefits alongside financial returns. The timing is critical as global challenges like climate change, health disparities, and economic inequality demand scalable solutions. Market forces favor firms that can bridge the gap between traditional venture capital and philanthropic funding by offering flexible financing and rigorous impact measurement. By supporting diverse founders and regional ecosystems, age1 helps decentralize innovation and promotes a more inclusive startup landscape, influencing how capital flows and how impact is integrated into investment decisions[1][3][4][6].
Looking ahead, age1 is poised to expand its influence by deepening its regional investments and refining its impact measurement frameworks. Trends such as climate tech innovation, health tech advancements, and digital inclusion will likely shape its portfolio focus. As impact investing matures, age1’s approach to reducing bias and fostering ecosystem connectivity could become a model for other funds seeking to balance profit with purpose. Its continued success will depend on scaling its unique investment model and demonstrating that impact-driven ventures can deliver competitive financial returns while addressing urgent global challenges[1][2][3][4][6].
